Aegicare
雅济科技 (Aegicare) is a high-tech enterprise focused on AI-empowered clinical precision diagnosis and treatment. The company's core team comprises members from US pharmaceutical industry listed companies and top universities worldwide. Aegicare leverages advanced bioinformatics, medical genetics, high-throughput sequencing, functional genomics, artificial intelligence, and cloud computing technologies to offer comprehensive clinical whole-genome solutions for patients, medical institutions, and research organizations. They have developed the AEGIS™ genomic intelligence platform, supported by their proprietary WEAVER™ bioinformatics analysis system. This platform utilizes a knowledge graph of over 100,000 Chinese rare disease patients' multi-omics data to provide precise and efficient bioinformatics analysis and rare disease genetic interpretation services for clinical applications. Aegicare has established strategic partnerships with over 300 top-tier hospitals across China and collaborates with Peking University's College of Engineering and Huazhong University of Science and Technology's Tongji Medical College to advance the intelligence of precision medicine. Their Shenzhen Anjicang'er Medical Laboratory, approved by the Health Commission, has passed over 40 inter-laboratory quality evaluations with a perfect score and holds over 100 intellectual property rights.
Aegicare
雅济科技 (Aegicare) is a high-tech enterprise focused on AI-empowered clinical precision diagnosis and treatment. The company's core team comprises members from US pharmaceutical industry listed companies and top universities worldwide. Aegicare leverages advanced bioinformatics, medical genetics, high-throughput sequencing, functional genomics, artificial intelligence, and cloud computing technologies to offer comprehensive clinical whole-genome solutions for patients, medical institutions, and research organizations. They have developed the AEGIS™ genomic intelligence platform, supported by their proprietary WEAVER™ bioinformatics analysis system. This platform utilizes a knowledge graph of over 100,000 Chinese rare disease patients' multi-omics data to provide precise and efficient bioinformatics analysis and rare disease genetic interpretation services for clinical applications. Aegicare has established strategic partnerships with over 300 top-tier hospitals across China and collaborates with Peking University's College of Engineering and Huazhong University of Science and Technology's Tongji Medical College to advance the intelligence of precision medicine. Their Shenzhen Anjicang'er Medical Laboratory, approved by the Health Commission, has passed over 40 inter-laboratory quality evaluations with a perfect score and holds over 100 intellectual property rights.